Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Palisade Bio (PALI)
NASDAQ:PALI
Holding PALI?
Track your performance easily
PALI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.38 - $22.35
Previous Close$1.4
Volume68.20M
Average Volume (3M)110.52K
Market Cap
$2.00M
Enterprise Value-$5.92M
Total Cash (Recent Filing)$8.04M
Total Debt (Recent Filing)$122.00K
Price to Earnings (P/E)―
Beta2.35
Next Earnings
Mar 14, 2025EPS Estimate
-$2.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-15.04
Shares Outstanding1,329,516
10 Day Avg. Volume6,970,052
30 Day Avg. Volume110,520
Standard Deviation0.27
R-Squared0.07
Alpha-0.09
Financial Highlights & Ratios
Price to Book (P/B)0.47
Price to Sales (P/S)7.45
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-23.69
Enterprise Value/Ebitda0.42
Forecast
1Y Price Target
$23.00Price Target Upside874.58% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Palisade Bio News
Ownership Overview
4.87% Insiders
1.04% Mutual Funds
3.65% Other Institutional Investors
90.12% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
PALI FAQ
What was Palisade Bio’s price range in the past 12 months?
Palisade Bio lowest stock price was $1.38 and its highest was $22.35 in the past 12 months.
What is Palisade Bio’s market cap?
Currently, no data Available
When is Palisade Bio’s upcoming earnings report date?
Palisade Bio’s upcoming earnings report date is Mar 14, 2025 which is in 91 days.
How were Palisade Bio’s earnings last quarter?
Palisade Bio released its earnings results on Nov 12, 2024. The company reported -$2.32 earnings per share for the quarter, beating the consensus estimate of -$3.353 by $1.033.
Is Palisade Bio overvalued?
According to Wall Street analysts Palisade Bio’s price is currently Undervalued.
Does Palisade Bio pay dividends?
Palisade Bio does not currently pay dividends.
What is Palisade Bio’s EPS estimate?
Palisade Bio’s EPS estimate is -$2.24.
How many shares outstanding does Palisade Bio have?
Palisade Bio has 1,425,292 shares outstanding.
What happened to Palisade Bio’s price movement after its last earnings report?
Palisade Bio reported an EPS of -$2.32 in its last earnings report, beating expectations of -$3.353. Following the earnings report the stock price went down -4.418%.
Which hedge fund is a major shareholder of Palisade Bio?
Currently, no hedge funds are holding shares in PALI
---
Palisade Bio Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$23.00 (874.58% Upside)
$23.00 (874.58% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▲ 2.9%
Last 30 Days ▼ 5.2%
Last 30 Days ▼ 5.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-84.64%
12-Months-Change
Fundamentals
Return on Equity
-135.96%
Trailing 12-Months
Asset Growth
-45.30%
Trailing 12-Months
Company Description
Palisade Bio
Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD.
---
PALI Stock 12 Month Forecast
Average Price Target
$23.00
▲(874.58% Upside)
Technical Analysis
Adial Pharmaceuticals
―
Bioxcel Therapeutics
―
Leap Therapeutics
―
Aurinia Pharmaceuticals
―
Best Analysts Covering PALI
1 Year
1 Year Success Rate
0/15 ratings generated profit
1 Year Average Return
-63.54%
reiterated a buy rating 10 days ago
Copying Naz Rahman's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -63.54% per trade.
---